ARQT R&D Expenses

Arcutis Biotherapeutics Inc · R&D Expenses

ARQT logo

ARQT R&D Expenses

Latest reported$20.36M
ARQT Quarterly R&D Expenses ($2.76M → $20.36M)
High-resolution chart · PNG

ARQT r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arcutis Biotherapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
20,355,000
30,627,000
20,451,000
19,604,000
19,453,000
17,543,000
14,480,000
19,501,000
19,298,000
23,141,000
23,775,000
26,236,000
25,219,000
35,345,000
33,877,000
69,731,000
38,205,000
40,622,000
52,558,000
40,604,000
30,765,000
21,631,000
27,374,000
32,743,000
30,009,000
25,182,000
10,757,000
12,348,000
7,214,000
6,203,000
5,347,000
7,081,000
2,756,000
2,756,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.